14 Jul 2024Open access
Epidemiology, outcomes and prognosis of infective endocarditis in Northern MoroccoPublisher siteBMC Infectious Diseases, Infective Endocarditis Diagnosis and Management
Active, last published 2026
In rheumatoid arthritis research and therapies
Ilias
Soussan
Scholar“Research focused on Rheumatoid Arthritis Research and Therapies and adjacent fields.”
Claim Your Profile2
H-index
22
Citations
Ilias has not officially claimed their profile. If you are Ilias, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
lias Soussan is a researcher working on Rheumatoid Arthritis Research and Therapies. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Ilias's work has been cited 22 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Rheumatoid Arthritis Research and Therapies×2Infective Endocarditis Diagnosis and Management×2Bacterial Identification and Susceptibility Testing×2
04 · Where I am
Affiliations
Affiliation on published researchAbdelmalek Essaâdi University, MoroccoDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works3 Apr 2024Open access
Epidemiology, Outcomes and Prognosis of Infective Endocarditis in Northern MoroccoPublisher siteResearch Square, Infective Endocarditis Diagnosis and Management
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Ilias?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you